metricas
covid
Buscar en
Medicina Clínica Práctica
Toda la web
Inicio Medicina Clínica Práctica Anemia among active Helicobacter pylori infection at the University Medical Cent...
Información de la revista
Vol. 7. Núm. 2.
(abril - junio 2024)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
4257
Vol. 7. Núm. 2.
(abril - junio 2024)
Original article
Acceso a texto completo
Anemia among active Helicobacter pylori infection at the University Medical Center Ho Chi Minh City: A case–control study
Anemia entre la infección activa por Helicobacter pylori en el Centro Médico Universitario de la Ciudad de Ho Chi Minh: Un estudio de casos y controles
Visitas
4257
Manh Tuan Haa,b, Viet Tung Lea,b,
Autor para correspondencia
tung.lv@umc.edu.vn

Corresponding author at: University Medicine Center Ho Chi Minh City, Ho Chi Minh City, Viet Nam (201 Nguyen Chi Thanh Str., District 5, Ward 12, Ho Chi Minh City, 700000, Viet Nam); University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City (217 Hong Bang Str., District 5, Ward 11, Ho Chi Minh City, 700000, Viet Nam)
, Phuong Duy Huynhc, Tuan Anh Nguyenb
a University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam
b University Medical Center Ho Chi Minh City, Ho Chi Minh City, Viet Nam
c Tra Vinh University, Tra Vinh City, Viet Nam
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (1)
Tablas (4)
Table 1. Baseline characteristics of the study population.
Table 2. Comparison of hematological and iron-related indices according to Helicobacter pylori infection status.
Table 3. Comparison of anemia, iron deficiency, and iron deficiency anemia between the H. pylori-positive group and H. pylori-negative group.
Table 4. Association between anemia, iron deficiency, and Helicobacter pylori infection in the study population using univariate and multivariate logistic regression analysis.
Mostrar másMostrar menos
Abstract
Background

Helicobacter pylori (H. pylori) infection may cause gastric ulcers or extra-gastroduodenal disorders, including iron deficiency anemia. This study aimed to determine the relationship between H. pylori infection and iron deficiency anemia (IDA).

Methods

A case–control study was conducted on participants aged ≥18 with an indication for gastric endoscopy. The cases were identified by positive rapid urease tests with biopsy specimens obtained during gastric endoscopy. The controls were negative rapid urease tests. Blood samples from the participants were taken for hematological indices and other iron-related parameters.

Results

A total of 230 participants including 115 cases and 115 controls were eligible for the study. H. pylori positive group had significantly a lower mean value of hemoglobin (P<.001), mean corpuscular volume (MCV) (P<.001), mean corpuscular hemoglobin concentration (MCHC) (P<.001), serum iron (P<.001), and transferrin saturation (TSAT) (p<.001) compared to the counterparts; meanwhile, ferritin levels showed an insignificant difference between 2 groups (P>.05). The rate of iron deficiency anemia was significantly higher in the cases than in the controls (χ2=16.05; P<.001). A significant association was found between H. pylori infection and anemia, iron deficiency with age and sex-adjusted ORs of 7.59 (95% CI=3.83–15.05, P<.001) and 2.12 (95% CI=1.05–4.25, P=.035), respectively.

Conclusions

Our study found a significant association between H. pylori infection and anemia, and iron deficiency. The relationship between H. pylori infection and iron deficiency anemia has not been conclusively established. H. pylori-infected individuals should be screened for IDA.

Keywords:
Anemia
Iron deficiency
Iron deficiency anemia
Helicobacter pylori infection
Abbreviations:
CI
Hb
Hct
H. pylori
IDA
IQR
MCHC
MCV
OR
RBC
RDW
TIBC
TSAT
SD
Resumen
Antecedentes

La infección por Helicobacter pylori (H. pylori) puede causar úlceras gástricas o trastornos extra-gastroduodenales, incluida la anemia por deficiencia de hierro. Este estudio tuvo como objetivo determinar la relación entre la infección por H. pylori y la anemia por deficiencia de hierro (IDA).

Métodos

Se llevó a cabo un estudio de casos y controles en participantes mayores de 18 años con indicación de endoscopia gástrica. Los casos fueron identificados por pruebas rápidas de ureasa positivas con muestras de biopsia obtenidas durante la endoscopia gástrica. Los controles tenían pruebas rápidas de ureasa negativas. Se tomaron muestras de sangre de los participantes para obtener índices hematológicos y otros parámetros relacionados con el hierro.

Resultados

Un total de 230 participantes, incluidos 115 casos y 115 controles, fueron elegibles para el estudio. El grupo positivo para H. pylori tuvo significativamente un valor medio más bajo de hemoglobina (p<0.001), volumen corpuscular medio (MCV) (p<0.001), concentración de hemoglobina corpuscular media (MCHC) (p<0.001), hierro sérico (p<0.001) y saturación de transferrina (TSAT) (p<0.001) en comparación con los contrapartes; mientras tanto, los niveles de ferritina mostraron una diferencia no significativa entre los dos grupos (p>0.05). La tasa de anemia por deficiencia de hierro fue significativamente mayor en los casos que en los controles (χ2=16.05; p<0.001). Se encontró una asociación significativa entre la infección por H. pylori y la anemia, con OR ajustadas por edad y sexo de 7.59 (IC del 95% = 3.83-15.05, p<0.001) y 2.12 (IC del 95% = 1.05-4.25, p=0.035), respectivamente.

Conclusión

Nuestro estudio encontró una asociación significativa entre la infección por H. pylori y la anemia, así como la deficiencia de hierro. La relación entre la infección por H. pylori y la anemia por deficiencia de hierro no se ha establecido de manera concluyente. Las personas infectadas con H. pylori deben ser evaluadas para detectar la IDA.

Palabras clave:
anemia
deficiencia de hierro
anemia por deficiencia de hierro
infección por Helicobacter pylori
Texto completo
Introduction

Helicobacter pylori (H. pylori) infection is one of the most common and persistent bacterial infections worldwide, with a wide variation of prevalence from 22% to 87%, especially in developing countries.1,2 The manifestations of H. pylori infection vary from asymptomatic to symptomatic. Disorders commonly caused by H. pylori infection are gastritis, peptic ulcer disease, gastric ulcers, and gastric cancer.3 In addition to gastroduodenal diseases, numerous studies have shown that H. pylori infection can cause disorders outside the gastrointestinal tract.4 Iron deficiency anemia is one of the most concerning disorders among extra-gastroduodenal disorders.4,5

Increasing evidence has reported an association between H. pylori infection and iron deficiency anemia (IDA).6–12 Many studies also found that eradication of H. pylori leads to improvement in iron deficiency anemia.6,12–14 This evidence indirectly supports the association between H. pylori infection and iron deficiency anemia. Given the association between H. pylori infection and iron deficiency anemia, several studies and guidelines suggest that H. pylori infection should be screened for and treated if detected in adults with unexplained iron deficiency anemia.6,14,15 The mechanism of H. pylori infection producing iron deficiency anemia has still been hypothesized. Blood loss due to bleeding from peptic ulcers, and hemorrhagic gastritis caused by H. pylori infection; inadequate iron absorption due to decreased levels of ascorbic acid and stomach acidity resulting from H. pylori chronic gastritis; and increased utilization of iron by H. pylori for their growth have been considered as mechanisms of iron deficiency anemia caused by H. pylori infection.4,5,16,17

However, some studies have reported that the association between H. pylori infection and iron deficiency anemia was not significant.18–20 Tseng et al even found no association between iron deficiency anemia and H. pylori infection and no improvement in iron deficiency anemia after H. pylori treatment.21 These findings suggest that the association between H. pylori infection and iron deficiency anemia is still conflicting due to differences in sampling method, the iron deficiency anemia criteria, and the prevalence of H. pylori infection in the study population among the studies.22 Iron deficiency anemia in individuals with H. pylori infection has not received much attention in Vietnam, although the prevalence of H. pylori infection in Vietnam is quite high at 70.3%1 and the proportion of anemia associated with iron deficiency among adults in Vietnam is high at 35.2%.23 This study aimed to determine the association between H. pylori infection and iron deficiency anemia to propose an approach to individuals infected with H. pylori.

Material and methodsStudy design and setting

A case–control study was conducted on participants who came for medical examinations and health check-ups at Branch 2 of the University Medical Center Ho Chi Minh City from December 2020 to June 2021. The University Medical Center is a hospital affiliated with the University of Medicine and Pharmacy at Ho Chi Minh City. It is one of the largest hospitals in Vietnam, located in Ho Chi Minh City; an average of 1000 outpatient visits, 70 upper gastrointestinal endoscopy cases, and 4000 tests per day are served at Branch 2.

Study participants and sampling

Participants over 18 years old who were examined, evaluated, and indicated for upper gastrointestinal endoscopy were included in the study. All participants signed written informed consent forms before participating in the study. Participants were asked to fast for a minimum of 4 h before the endoscopy. The case group included those whose biopsy samples taken by endoscopy were positive with rapid urease tests. The control group included those whose biopsy samples were negative with the rapid urease tests. The ratio of the case: control was 1:1 with matching sex and age. A consecutive sampling was performed to collect data. Exclusion criteria were as follows: (1) the participants who took antibiotics for H. pylori in the 4 weeks before endoscopy or took proton pump inhibitors in the 2 weeks before endoscopy; (2) the participants who were taking non-steroid anti-inflammatory drugs; (3) those who had diseases that cause anemia or affect hematopoiesis such as malignancies, hematological diseases, and chronic diseases; (4) those who were pregnant, menstruating, and breastfeeding women; (5) those who showed signs of active bleeding (melena, hematemesis, hematuria, epistaxis).

Laboratory measurements

Blood collecting was performed before the endoscopy. Each participant had 5 ml of venous blood drawn in the morning after fasting for at least 8 h. 2.5 ml of blood was collected into an EDTA tube for analysis of hematological parameters including hemoglobin (Hb) level, hematocrit (Hct), red blood cell (RBC) count, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), and red cell distribution width (RDW). Blood samples were analyzed using the Alnity analyzer (Abbott Diagnostics, Ireland). Reference range values for MCV, MCH, MCHC, and RDW are 80–100 fL, 28–35 pg, 32–36 g/dL, and 11%–15%, respectively.16 The remaining 2.5 ml of blood was collected into a serum tube for measurement of iron-related parameters including serum iron, ferritin, transferrin, total iron-binding capacity (TIBC), and transferrin saturation (TSAT). The iron, ferritin, and transferrin indices were measured with an electrochemiluminescence immunoassay (Beckman Coulter AU680 Chemistry Analyzer, USA). The reference range values for serum iron, ferritin, and transferrin were 50–160 μg/dL, 30–400 ng/mL, and 2.0–3.6 g/L, respectively.16 Total iron binding capacity (TIBC) was calculated by the formula: TIBC (μg/dL)=Transferrin (mg/dL)×1.25.24 The reference range value for TIBC was 255–450 μg/dL. Transferrin saturation (TSAT - Transferrin saturation) was calculated by the formula: TSAT=(Serum iron/TIBC)×100%. The reference range value for TSAT was 20%–50%.16

Determination of H. pylori infection

Biopsy specimens taken from performing endoscopy were analyzed for H. pylori determination using a rapid urease test (CLO test, Kimberley-Clark, USA). The specimens were processed according to the manufacturer's instructions, and the results were read within 30 min. A change of gel color from yellow to magenta (purple-red) was considered a positive for H. pylori.

Definition of anemia, iron deficiency, and iron deficiency anemia

Anemia was defined according to the criteria established by the World Health Organization, with hemoglobin levels below 13 g/dL in men and 12 g/dL in women.25 Iron deficiency was defined as serum ferritin <30 ng/mL. Iron deficiency anemia was defined as anemia associated with: (1) Serum ferritin level <30 ng/mL; (2) TSAT <20 %; (3) MCH <28 pg.26,27 Microcytic hypochromic anemia was defined as anemia with MCV <80 fL and MCH <28 pg; normocytic normochromic anemia was defined as anemia with 80 fLMCV100 fL and 28 pgMCH35 pg; normocytic hypochromic anemia was defined as anemia with MCV <80 fL and 28 pgMCH35 pg.

Ethical consideration

All participants were voluntary to participate in the study and signed written informed consent before being recruited in the study. All participants can withdraw from the study without any consequences and at any time. The data forms were coded and anonymous. All participants’ data were confidential. This study was approved by the Ethics Committee for Biomedical Research of the University of Medicine and Pharmacy at Ho Chi Minh City under Decision No. 838/HĐĐĐ-ĐHYD issued on November 9, 2020.

Statistical analyses

Statistical analyses were performed using STATA version 15.1. Baseline characteristics for categorical variables were presented as frequencies and proportions, while means and standard deviations, or medians and interquartile ranges, were used for continuous variables. Student's t-test was employed for normally distributed continuous variables, and the non-parametric Mann–Whitney U test was used for non-normally distributed continuous variables to compare differences between the two groups. The χ2 test was employed to compare differences for categorical data. Univariate and multivariate logistic regression was used to calculate the odds ratio (OR) and 95% confidence interval (CI) with dependent variables including anemia, iron deficiency, and iron deficiency anemia. The multivariate logistic regression models were adjusted for sex and age. A two-sided P-value of less than .05 was considered statistically significant.

ResultsBaseline characteristics of participants

This study included 115 subjects in the H. pylori-positive group and 115 subjects in the H. pylori-negative group. Table 1 shows the characteristics of the study population. The mean age of the study population was 44.5±12.3 years, males accounted for 44.4% of the total population. Two-thirds of the cohort lived in urban areas, most of the participants were employed (92.6%), and Kinh ethnicity accounted for 76.5% of the total. There were no significant differences in age, sex, occupational status, residency, and ethnicity between the cases and controls.

Table 1.

Baseline characteristics of the study population.

VariablesOverall  H. pylori (+)  H. pylori (–)  P values
n=230  n=115  n=115 
Age (mean±SD)  44.5±12.3  43.2±13.2  45.9±11.2  .096b 
Age groups (%)
30  30 (13.1)  21 (18.3)  9 (7.8)  .052a
31–40  47 (20.5)  21 (18.3)  26 (22.6) 
41–50  82 (35.6)  41 (35.6)  41 (35.6) 
51–60  50 (21.7)  19 (16.5)  31 (27.0) 
>61  21 (9.1)  13 (11.3)  8 (7.0) 
Sex (%)
Male  102 (44.4)  53 (46.1)  49 (42.6)  .595a
Female  128 (55.6)  62 (53.9)  66 (57.4) 
Occupation (%)
Employed  213 (92.6)  107 (93.0)  106 (92.3)  .801a
Unemployed  17 (7.4)  8 (7.0)  9 (7.8) 
Residency (%)
Urban  152 (66.1)  72 (62.6)  80 (69.6)  .365a
Rural  78 (33.9)  43 (37.4)  35 (40.4) 
Ethnicity (%)
Kinh  176 (76.5)  84 (73.0)  92 (80.0)  .213a
Others  54 (23.5)  31 (27.0)  23 (20.0) 
a

Chi-square test.

b

Student's t-test.

Comparison of hematological indices and iron-related parameters between Helicobacter pylori-infected individuals and Helicobacter pylori-uninfected individuals

Table 2 shows the hematological indices and iron-related parameters between the 2 groups. The mean serum iron of the H. pylori-positive group was 59.4±42.1 μg/dL which was significantly lower than that of the H. pylori-negative group (88.1±32.5 μg/dL) (P<.001) (Table 2, Fig. 1A). Similarly, the mean TSAT value was significantly lower in the H. pylori-positive group compared to the counterparts (18.6±13.8% vs. 25.9±9.7%; P<.001) (Table 2, Fig 1D). Otherwise, there was no significant difference in serum ferritin, transferrin, and TIBC levels between the 2 groups (P>.05) (Table 2, Fig. 1B). The mean hemoglobin (Hb) concentration of the H. pylori-positive group was significantly lower than that of the H. pylori-negative group (12.6±2.2 g/dL vs. 13.9±1.4 g/dL, P<.001) (Table 2, Fig. 1C). Other hematological parameters, such as Hct (39.0±6.5% vs. 42.2±4.0%, P<.001), MCV (81.0±10.6 fL vs. 88.5±6.0 fL, P<.001), MCH (27.3±4.0 pg vs. 29.1±2.1 pg, P<.001), and MCHC (32.6 [31.2–33.6] vs. 32.9 [32.3–33.6], P=.03) also had the same difference as Hb between the case group and control group. However, RDW values were significantly higher in the H. pylori-infected individuals compared to their counterparts (14.1±1.6% vs. 12.9±0.9%, P<.001). Mean RDW values in the H. pylori-infected group having microcytic hypochromic anemia were 14.6±0.9% (data not shown in Table 2). Mean RBC counts were not significantly different between the 2 groups (P=.278).

Table 2.

Comparison of hematological and iron-related indices according to Helicobacter pylori infection status.

VariablesOverall  H. pylori (+)  H. pylori (–)  P values
n=230  n=115  n=115 
Serum iron (μg/dL)a  73.8±40.2  59.4±42.1  88.1±32.5  <.001c 
Serum transferrin (g/L)a  2.5±0.5  2.4±0.6  2.4±0.4  .865c 
Serum ferritin (ng/mL)b  122.7 [42.4–208.3]  103.5 [30.4–389.5]  133.1 [56.6–224.1]  .623d 
Serum TIBC (μg/dL)a  346.8±77.4  346.3±92.3  347.3±59.2  .922c 
TSAT (%)a  22.3±12.4  18.6±13.8  25.9±9.7  <.001c 
Hemoglobin (g/dL)a  13.2±2.0  12.6±2.2  13.9±1.4  <.001c 
RBC (×1012/L)a  4.7±0.8  4.7±0.9  4.8±0.6  .278c 
Hct (%)a  40.6±5.6  39.0±6.5  42.2±4.0  <.001c 
MCV (fL)a  84.8±9.4  81.0±10.6  88.5±6.0  <.001c 
MCH (pg)a  28.2±3.3  27.3±4.0  29.1±2.1  <.001c 
MCHC (g/dL)b  32.8 [31.9–33.6]  32.6 [31.2–33.6]  32.9 [32.3–33.6]  .030d 
RDW (%)a  13.5±1.4  14.1±1.6  12.9±0.9  <.001c 

TIBC: total iron binding capacity; TSAT: transferrin saturation; RBC: red blood cell; Hct: hematocrit; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration. RDW: red cell distribution width.

a

Mean±standard deviation.

b

Median [interquartile range].

c

Student’s t-test.

d

Mann–Whitney U test.

Fig. 1.

Boxplot chart comparing hematological parameters in the H. pylori-positive and H. pylori-negative groups. (A) Serum iron; (B) serum ferritin; (C) hemoglobin; (D) TSAT.

(0.14MB).
The association between anemia, iron deficiency, iron deficiency anemia, and Helicobacter pylori infection status

The rate of anemia, iron deficiency, and iron deficiency anemia in the H. pylori-positive group was significantly higher than that in the H. pylori-negative group (χ2=38.57; χ2=4.83; and χ2=16.05; P<.001, respectively) (Table 3). The rate of microcytic hypochromic anemia accounted for 52.5% of total cases of anemia in H. pylori-infected individuals (31/59) (Table 3). The rate of microcytic hypochromic anemia is significantly higher in the case group than in the control group (χ2=35.83, P<.001). In contrast, there was no significant difference in other types of anemia between the cases and the controls (P>.05) (Table 3).

Table 3.

Comparison of anemia, iron deficiency, and iron deficiency anemia between the H. pylori-positive group and H. pylori-negative group.

VariablesOverall  H. pylori (+)  H. pylori (–)  χ2 valueP values
n=230  n=115  n=115 
Anemia
Yes  74 (32.2)  59 (51.3)  15 (13.0)  38.57 (OR=7.02)<.001a
No  156 (67.8)  56 (48.7)  100 (87.0) 
Microcytic hypochromic anemia
Yes  31 (13.5)  31 (27.0)  0 (0.0)  35.83<.001b
No  199 (86.5)  84 (73.0)  100 (100.0) 
Normocytic normochromic anemia
Yes  25 (10.9)  12 (10.4)  13 (11.3)  0.05 (OR=0.91).832a
No  205 (89.1)  103 (89.6)  102 (88.7) 
Normocytic hypochromic anemia
Yes  6 (2.6)  4 (3.5)  2 (1.7)  0.68 (OR=2.04).683b
No  224 (97.4)  111 (96.5)  113 (98.3) 
Iron deficiency
Yes  43 (18.7)  28 (24.4)  15 (13.0)  4.83 (OR=2.15).028a
No  187 (81.3)  87 (75.6)  100 (87.0) 
Iron deficiency anemia
Yes  15 (6.5)  15 (13.0)  0 (0.0)  16.05<.001b
No  215 (93.5)  100 (87.0)  115 (100.0) 

OR: odds ratio.

a

Chi-square test.

b

Fisher's exact test.

The association between H. pylori infection and anemia, and iron deficiency is shown in Table 4. In the univariate logistic regression analysis, anemia was found to be associated with H. pylori infection (OR=7.02; 95% CI=3.52–14.49) and male sex (OR=2.69; 95% CI=1.47–4.97). Iron deficiency was only associated with H. pylori infection (OR=2.15; 95% CI=1.03–4.61), but insignificantly related to age and male sex (P>.05). In the multivariate logistic regression analyses, a significant association was found between H. pylori infection and anemia, and iron deficiency with an age and sex-adjusted odds ratio (aOR) of 7.59 (95% CI=3.83–15.05, P<.001) and 2.12 (95% CI=1.05–4.25, P=.035), respectively (Table 4).

Table 4.

Association between anemia, iron deficiency, and Helicobacter pylori infection in the study population using univariate and multivariate logistic regression analysis.

VariablesUnivariate logistic regressionMultivariate logistic regression
OR (95% CI)  P values  adjusted OR (95% CI)  P values 
Anemia
H. pylori status (Yes)  7.02 (3.52–14.49)  <.001  7.59 (3.83–15.05)  <.001 
Sex (Male)  2.69 (1.47–4.97)  <.001  3.09 (1.64–5.85)  <.001 
Age  0.99 (0.97–1.01)  .430  0.99 (0.97–1.02)  .878 
Iron deficiency
H. pylori status (Yes)  2.15 (1.03–4.61)  .028  2.12 (1.05–4.25)  .035 
Sex (Male)  0.69 (0.34–1.44)  .296  0.67 (0.34–1.34)  .264 
Age  0.98 (0.96–1.01)  .273  0.99 (0.96–1.02)  .403 

OR: odds ratio; CI: confidence interval. Adjusted OR: adjusted for age, and sex.

Discussion

This study aimed to determine the association between H. pylori infection and iron deficiency anemia. The study results showed that there was a significant association between H. pylori infection and anemia, and iron deficiency, and the rate of iron deficiency anemia in H. pylori-infected individuals was significantly higher than that in the H. pylori-uninfected individuals.

There was a significant relationship between H. pylori infection and iron deficiency in this study (aOR=2.12, 95% CI=1.05–4.25, P=.035). This finding is consistent with many previous studies.9,10,14,18,28–30 However, this present study found a discrepancy between changes in serum iron levels and serum ferritin levels in H. pylori-infected individuals. Both the serum iron and ferritin levels should be lower in the H. pylori-infected individuals compared to the H. pylori-uninfected ones due to iron deficiency related to H. pylori infection. However, only serum iron levels in H. pylori-positive individuals were significantly lower than those in H. pylori-negative individuals (59.4±42.1 μg/dL vs. 88.1±32.5 μg/dL, P<.001). In contrast, the median serum ferritin levels in the case group did not show significantly lower compared to the control group (103.5 [30.4–389.5] vs. 133.1 [56.6–224.1] (ng/mL), P=.623) in this study. This discrepancy was also reported in some studies.18,19,29,31 Hou et al. also noted no difference in serum ferritin levels between the H. pylori-infected group and the H. pylori-uninfected group (165.5 [109.80–272.75] vs. 186.10 [107.30–273.60], P=.903).20 Kishore et al. even noted that the serum ferritin level was higher in the H. pylori-infected group than in the H. pylori-uninfected group (536.82±117.0 ng/dL vs. 391.31±101.54 ng/dL, P<.001).32 This can be explained by the role of ferritin in the body which is a biomarker reflecting both the body's iron storage status and an inflammatory response. H. pylori infection causes a chronic inflammatory condition that increases ferritin levels, it consequently contributes to the normal or elevated serum ferritin levels despite iron deficiency arising from H. pylori infection.5,16,26,33

This study also found that the mean TSAT levels were less than 20% and the median ferritin levels were ≥100 ng/mL in H. pylori-infected individuals. High serum ferritin with low TSAT levels may imply dysutilization of iron for erythropoiesis.34 This condition can be caused by H. pylori infection which activates an inflammatory response mediated by Interleukin 6 leading to an increase in hepcidin. This substance binds ferroportin, a transmembrane protein found mainly in macrophages and enterocytes. This binding leads to cellular ferroportin internalization and degradation, subsequently decreasing iron availability for erythropoiesis. This is also a mechanism that contributes to the pathogenesis of anemia due to H. pylori infection.5

The association between H. pylori infection and anemia was also recorded in this study with aOR=7.59, 95% CI=3.83–15.05 (P<.001). This result is in line with previous studies.11,20,35–37 In addition, this study found that the cases of microcytic hypochromic anemia which occurred predominantly in H. pylori-infected individuals had mean RDW values of more than 14%. These findings indicate that iron deficiency is likely to be a cause of anemia in H. pylori-infected people.16,33,38 The predominance of microcytic hypochromic anemia in the case group is not in agreement with some studies.13,20 These studies reported normocytic normochromic anemia arising from H. pylori-infected individuals. This could be explained that iron deficiency anemia is detected in an early stage in these studies, thus MCV and MCH indices are not much affected.16,26 In addition, coexisting vitamin B12 deficiency which is caused by gastritis due to H. pylori infection can result in anemia without microcytosis despite existing iron deficiency.13,26

There was no case of iron deficiency anemia found in the control group, so our study only compared the rate of iron deficiency anemia between the 2 groups with a chi-square test instead of using multivariate regression analysis to identify the association between them. This study noted that the rate of iron deficiency anemia in H. pylori-infected people was significantly higher than that in H. pylori-uninfected people (13% vs. 0%, χ2=16.05, P<.001). Furthermore, H. pylori infection significantly associated with iron deficiency and anemia were found in the present study as described above. Microcytic hypochromic anemia, a type of anemia caused by iron deficiency, predominated in the cases of anemia occurring in H. pylori-infected individuals as well. These findings suggest a potential relationship between H. pylori infection and iron deficiency anemia. The association between H. pylori infection and iron-deficiency anemia has also been demonstrated in previous studies.6,7,9,12 However, in this study, the ferritin levels did not show a significant difference between the H. pylori-infected group and the H. pylori-uninfected group, and the IQR of median ferritin levels in the case group was wider than that in the control group. Therefore, iron deficiency as the primary cause of anemia in H. pylori-infected patients has not been conclusively established. The anemia in individuals infected with H. pylori may be caused by iron deficiency, chronic H. pylori infection, or a combination of both in the present study. Further studies are needed to ascertain whether iron deficiency is the primary cause of anemia in H. pylori-infected individuals or not.

The exact mechanism of iron deficiency anemia in patients with H. pylori infection remains unclear. However, there are several mechanisms through which H. pylori infection results in iron deficiency anemia that have been investigated. First, gastritis caused by H. pylori infection leads to decreased levels of ascorbic acid and stomach acidity. These in turn contribute to decreased absorption of dietary iron and thus the pathogenesis of iron deficiency anemia.4,5,12 The CagA-positive H. pylori strains were presumed to have a relationship with reduced levels of ascorbic acid in the stomach.12 Second, H. pylori require iron for their growth, so bacteria will increase iron acquisition directly from the stomach’s contents, consequently reducing the iron amount available to the host.4,5,12H. pylori can directly acquire iron by sequestering lactoferrin from the gastric mucosa of the host through a receptor for lactoferrin in its membrane.5 Third, bleeding from peptic ulcers and hemorrhagic gastritis caused by H. pylori are other possible mechanisms that can cause or contribute to iron deficiency.4,5,12 Finally, the role of hepcidin as presented earlier which contributes to the dysutilization of iron for erythropoiesis is a possible explanation of iron deficiency anemia due to H. pylori infection.5 The mechanisms of H. pylori infection leading to iron deficiency anemia mentioned above also imply that iron deficiency anemia can occur in both symptomatic and asymptomatic H. pylori infections.5,12 This may be meaningful in clinical practice, the screening for iron deficiency anemia should be performed in persons infected with H. pylori regardless of their clinical manifestations.

To the best of our knowledge, this is the first study to identify the association between iron deficiency anemia and H. pylori infection in the Vietnamese population. However, this study had some limitations. Firstly, the sample size was relatively small as compared to previous studies, which may have affected the significance of the results. However, a sample size of 115 cases and 115 controls is still sufficient to yield meaningful results. Furthermore, the study was conducted using rigorous methods, with accurate data collection and appropriate statistical analysis. It was conducted at the University Medical Center, so the results can be considered valid for the study population. Secondly, the study did not test fecal occult blood for upper gastrointestinal bleeding to rule out cases of anemia due to blood loss, and measurement of sTfR (soluble transferrin receptor) has not yet been performed to distinguish between anemia caused by iron deficiency and anemia caused by chronic disease or inflammation. Finally, the study results just show the significant association between H. pylori infection and anemia; the cohort study is needed to identify whether H. pylori infection is a cause of iron deficiency anemia.

Conclusions

This study has shown a significant association between H. pylori infection and anemia, and iron deficiency. The relationship between H. pylori and iron deficiency anemia remains inconclusive and needs further studies. However, these results remain meaningful in the context that the prevalence of H. pylori infection is still high, and iron deficiency anemia is a health problem in Vietnam as well. The study results suggest that tests for iron deficiency anemia should be performed routinely in the management of individuals infected with H. pylori.

Financial support and sponsorship

None.

Acknowledgments

We highly appreciate the support from the University Medical Center Ho Chi Minh City - Branch 2.

References
[1.]
J.K.Y. Hooi, W.Y. Lai, W.K. Ng, et al.
Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis.
Gastroenterology, 153 (2017), pp. 420-429
[2.]
M. Zamani, F. Ebrahimtabar, V. Zamani, et al.
Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection.
Aliment Pharmacol Ther, 47 (2018), pp. 868-876
[3.]
E. Garza-Gonzalez, G.I. Perez-Perez, H.J. Maldonado-Garza, F.J. Bosques-Padilla.
A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.
World J Gastroenterol, 20 (2014), pp. 1438-1449
[4.]
F.W. Tsay, P.I. Hsu.
H. pylori infection and extra-gastroduodenal diseases.
J Biomed Sci, 25 (2018), pp. 65
[5.]
W.O.R. José Augusto Urrego Díaz, M.G. Zuleta.
Helicobacter pylori and hematologic diseases.
Rev Col Gastroenterol, 28 (2013), pp. 324-331
[6.]
J. Mulayamkuzhiyil Saju, N. Mandal, N.I. Kham, et al.
Is Helicobacter pylori a reason for unexplained iron deficiency anemia: a systematic review.
Cureus, 14 (2022),
[7.]
X.H. Qu, X.L. Huang, P. Xiong, et al.
Does Helicobacter pylori infection play a role in iron deficiency anemia?A meta-analysis.
World J Gastroenterol, 16 (2010), pp. 886-896
[8.]
M.A. Mubaraki, A.S. Alalhareth, E. Aldawood, et al.
The iron deficiency anemia in association to Helicobacter pylori infection in Najran city, Saudi Arabia.
J King Saud Univ Sci., 34 (2022),
[9.]
B.B. Eyoum Bille, L.B. Kouitcheu Mabeku.
Relationship between active Helicobacter pylori infection and anemia, iron deficiency, iron deficiency anemia: a cross-sectional study in a sub-Saharan setting.
JGH Open, 6 (2022), pp. 554-568
[10.]
V.M. Cardenas, Z.D. Mulla, M. Ortiz, D.Y. Graham.
Iron deficiency and Helicobacter pylori infection in the United States.
Am J Epidemiol, 163 (2006), pp. 127-134
[11.]
Y.A. Rahman, LAw Ahmed, R.M.M. Hafez, R.M.M. Ahmed.
Helicobacter pylori and its hematological effect.
Egypt J Intern Med, 31 (2019), pp. 332-342
[12.]
L. Hudak, A. Jaraisy, S. Haj, K. Muhsen.
An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia.
Helicobacter, 22 (2017),
[13.]
S.N. Mwafy, W.M. Afana.
Hematological parameters, serum iron and vitamin B(12) levels in hospitalized Palestinian adult patients infected with Helicobacter pylori: a case-control study.
Hematol Transfus Cell Ther, 40 (2018), pp. 160-165
[14.]
K. Miernyk, D. Bruden, C. Zanis, et al.
The effect of Helicobacter pylori infection on iron stores and iron deficiency in urban Alaska Native adults.
Helicobacter, 18 (2013), pp. 222-228
[15.]
W.D. Chey, G.I. Leontiadis, C.W. Howden, S.F. Moss.
ACG clinical guideline: treatment of Helicobacter pylori infection.
Am J Gastroenterol, 112 (2017), pp. 212-239
[16.]
M. Muñoz, I. Villar, J.A. García-Erce.
An update on iron physiology.
World J Gastroenterol, 15 (2009),
[17.]
J. Snook, N. Bhala, I.L.P. Beales, et al.
British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults.
[18.]
J.Y. Lee, S.E. Kim, S.J. Park, et al.
Helicobacter pylori infection and iron deficiency in non-elderly adults participating in a health check-up program.
Korean J Intern Med, 37 (2022), pp. 304-312
[19.]
S. John, J.D. Baltodano, N. Mehta, K. Mark, U. Murthy.
Unexplained iron deficiency anemia: does Helicobacter pylori have a role to play?.
Gastroenterol Rep (Oxf), 6 (2018), pp. 215-220
[20.]
B. Hou, M. Zhang, M. Liu, et al.
Association of active Helicobacter pylori infection and anemia in elderly males.
BMC Infect Dis, 19 (2019), pp. 228
[21.]
D.S. Tseng, D. Li, S.M. Cholleti, J.C. Wei, Y. Jodesty, H.V. Pham.
Effect of Helicobacter pylori treatment on unexplained iron deficiency anemia.
Perm J, (2019), pp. 23
[22.]
A.J. Lauren Hudak, S. Haj, K. Muhsen.
An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia.
Helicobacter, 22 (2017),
[23.]
N. Petry, I. Olofin, R.F. Hurrell, et al.
The proportion of anemia associated with iron deficiency in low, medium, and high human development index countries: a systematic analysis of national surveys.
Nutrients, 8 (2016),
[24.]
S.I. Hachiro Yamanishi, Y. Yamaguchi, Y. Kanakura, Y. Iwatani.
Total iron-binding capacity calculated from serum transferrin concentration or serum iron concentration and unsaturated iron-binding capacity.
Clin Chem, 49 (2003),
[25.]
World Health Organization.
Worldwide Prevalence of Anemia 1993– 2005 WHO Global Database on Anemia.
World Health Organization, (2008),
[26.]
M. Munoz, J.A. Garcia-Erce, A.F. Remacha.
Disorders of iron metabolism. Part II: iron deficiency and iron overload.
J Clin Pathol, 64 (2011), pp. 287-296
[27.]
C. Camaschella.
Iron-deficiency anemia.
N Engl J Med, 372 (2015), pp. 1832-1843
[28.]
GnB Gabriele Berg, M. Blettner, H. Boeing, H. Brenner.
Helicobacter pylori infection and serum ferritin a population based study among 1806 adults in Germany.
Am J Gastroenterol, (2001), pp. 1014-1018
[29.]
S. Nakagawa, T. Shimoyama, S. Sato, et al.
Decreased iron stores in patients with Helicobacter pylori infection is improved by eradication without corresponding changes in the intake of iron and vitamin C.
Cogent Medicine, 5 (2018),
[30.]
S.M.A. Sadat, A.R. Siddique, A. Saeed, et al.
Association between Helicobacter pylori infection and iron deficiency anemia: a cross sectional Study.
J Bangl Coll Physic Surg, 38 (2020), pp. 68-78
[31.]
D. Enko, H. Wagner, G. Kriegshauser, et al.
Iron status determination in individuals with Helicobacter pylori infection: conventional vs. new laboratory biomarkers.
Clin Chem Lab Med, 57 (2019), pp. 982-989
[32.]
G. Kishore, M. Ejaz, J. Kumar, et al.
Association between Helicobacter pylori infection and serum iron profile.
Cureus, 13 (2021),
[33.]
T.D. Johnson-Wimbley, D.Y. Graham.
Diagnosis and management of iron deficiency anemia in the 21st century.
Therap Adv Gastroenterol, 4 (2011), pp. 177-184
[34.]
T. Kuragano, N. Joki, H. Hase, et al.
Low transferrin saturation (TSAT) and high ferritin levels are significant predictors for cerebrovascular and cardiovascular disease and death in maintenance hemodialysis patients.
PLoS One, 15 (2020),
[35.]
B.G. Dargaze Kibru, A. Alemu, Z. Addis.
Helicobacter pylori infection and its association with anemia among adult dyspeptic patients attending Butajira Hospital.
BMC Infect Dis, 14 (2014), pp. 656
[36.]
M.Y. Xu, B. Cao, B.S. Yuan, J. Yin, L. Liu, Q.B. Lu.
Association of anaemia with Helicobacter pylori infection: a retrospective study.
[37.]
D. Asiimwe, I. Bangi, J. Esanyu, et al.
Association between Helicobacter pylori infection and anemia among adult dyspeptic patients attending Kiryandongo General Hospital, Uganda.
J Blood Med, 14 (2023), pp. 57-66
[38.]
K.A.A.J. Rahma Al Hadhrami, K. Al Balushi, A.J. Al Shaaib.
Validity of red cell distribution width versus red cell distribution width index to differentiate between iron deficiency anemia and β- thalassemia trait in an adult Omani population: a cross-sectional study contagiosity: a review.
Primary Health Care: Open Access, 11 (2021), pp. 400
Copyright © 2023. The Author(s)
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos